Page 2 - Advancing Point News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UMass Medical School helps lead NIH RADx to accelerate new COVID test technologies Project has increased U.S. testing capacity by more than 180 million tests By Susan E.W. Spencer April 01, 2021 While the acceleration of COVID-19 vaccinations has received much attention, the national effort to bring convenient, affordable and rapid testing technology for SARS-CoV-2 infection to market is also moving full speed ahead. In addition to the original mission to make tests more available, researchers are investigating lingering questions about COVID transmission. ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES ... Daxor CorporationFebruary 5, 2021 GMT NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has been awarded a grant from the Center for Advancing Point of Care Technologies (CAPCaT), a program run by the Massachusetts Medical Device Development Center (M2D2) funded by the National Heart, Lung, and Bloo...

Top story: UMass Medical School receives $100 million in NIH grants to lead push for fast, accessible COVID-19 tests By Susan E.W. Spencer December 28, 2020 As this unprecedented year comes to a close, the Office of Communications is rerunning some of the big stories of 2020 that highlight the incredible work of the UMass Medical School community. From the first-in-the-nation early graduation of our medical students to the essential clinical research that lead to a SARS-CoV-2 vaccine, from the tremendous growth of the institution’s research funding to gro...

Top story: NIH research funding surges at UMass Medical School COVID studies drive 78 percent first quarter spike in federal funding over last year UMass Medical School Communications December 21, 2020 As this unprecedented year comes to a close, the Office of Communications is rerunning some of the big stories of 2020 that highlight the incredible work of the UMass Medical School community. From the first-in-the-nation early graduation of our medical students to the essential clinical research that lead to a SARS-CoV-2 vaccine, from the tremendous growth of the institution’s re...

Meridian Bioscience receives NIH Award for supporting rapid development of Revogene® molecular test for SARS-CoV-2 CINCINNATI, Dec. 16, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has been awarded funding in the amount of approximately $1M by the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADx SM) initiative, to expedite the launch of the company’s SARS-CoV-2 molecular diagnostic test on the Revogene ® platform. On December 7, the applicatio...